10th week of 2010 patent applcation highlights part 47 |
Patent application number | Title | Published |
20100063112 | POLYMORPH III OF 4-[4-(AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE - The present invention relates to the polymorph III of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide, to processes for its preparation, to pharmaceutical compositions comprising it and to its use in the control of disorders. | 2010-03-11 |
20100063113 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR - The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I. | 2010-03-11 |
20100063114 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES - The present invention is directed to novel compounds. These compounds can be useful in inhibiting the activity of GGTase I. The compounds can also be used as anti-cancer therapeutics including as part of methods for treating cancer, in assays, and in kits. | 2010-03-11 |
20100063115 | 5-(1,3,4-OXADIAZOL-2-YL)-1H-INDAZOLE AND 5-(1,3,4-THIADIAZOL-2-YL)-1H-INDAZOLE DERIVATIVES AS SGK INHIBITORS FOR THE TREATMENT OF DIABETES - Novel aminoindazolylurea derivatives of the formula (I), in which L, X, Y, R | 2010-03-11 |
20100063116 | USE OF PRAMIPEXOLE OR A SALT THEREOF FOR THE TREATMENT OF PARKINSON'S DISEASE - The present invention refers to the use of pramipexole, pramipexole hydrochloride, pramipexole dihydrochloride or pramipexole dihydrochloride monohydrate for the manufacture of a medicament for the treatment of early Parkinson's disease by a maintenance, twice daily application. | 2010-03-11 |
20100063117 | Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient - Novel oxazolidinone derivatives with a difluorophenyl moiety, represented by Chemical Formula 1, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition containing the same as an active ingredient are provided. Exhibiting potent inhibitory activity against Gram-positive bacteria including | 2010-03-11 |
20100063118 | Hydantoins Having RNase Modulatory Activity - The present invention relates to hydantoin derivatives having RNase H, polymerase and/or HIV reverse transcriptase modulatory, and particularly, inhibitory activity. Included in the invention are the hydantoin derivatives, compositions containing the derivatives, methods of synthesis of the derivatives, screening methods to identify the derivatives, and methods of treatment using the hydantoin derivatives, including the treatment of HIV, AIDS and retrovirus-associated cancer. | 2010-03-11 |
20100063119 | SUBSTITUTED CARBINOL COMPOUND - There is provided a novel LXRβ agonist useful as a preventative and/or therapeutic agent for arteriosclerosis; arteriosclerosis such as those resulting from diabetes; hyperlipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases caused by inflammatory cytokines, skin diseases such as allergic skin diseases, diabetes or Alzheimer's disease. The agonist is a carbinol derivative represented by the following general formula (1) or salt thereof, or their solvate. | 2010-03-11 |
20100063120 | Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such - Compounds of formula (I): wherein X is O or S, R | 2010-03-11 |
20100063121 | Macrocyclic Heterocyclic Aspartyl Protease Inhibitors - Disclosed are compounds of the formula I | 2010-03-11 |
20100063122 | NOVEL 2-(2-HYDROXYPHENYL)BENZIMlDAZOLES USEFUL FOR TREATING OBESITY AND DIABETES - The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful, inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith. | 2010-03-11 |
20100063123 | EXTENDED RELEASE FORMULATION AND METHOD OF TREATING ADRENERGIC DYSREGULATION - A composition and method of treating adrenergic dysregulation by administering the composition is disclosed, wherein the composition comprises a a2-adrenergic receptor agonist; a pharmaceutically acceptable hydrophilic matrix and a release-retardant of a metal alkyl sulfate. In embodiments, the composition provides a sustained release of the agonist, wherein after administration of the composition no more than once about every 12 hours to a subject having a steady state plasma concentration of the a2-adrenergic receptor agonist, the agonist's plasma concentration peak-to-trough ratio is no greater than about 1.9. | 2010-03-11 |
20100063124 | NEW PYRAZOLE DERIVATIVES AND DIABETIC MEDICINE CONTAINING THEM - The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine. | 2010-03-11 |
20100063125 | MELATONIN DERIVATIVES AND THEIR USE AS ANTIOXIDANTS - The present subject matter relates generally to antioxidant compounds having the formula (I): wherein each of R | 2010-03-11 |
20100063126 | Carbazole-Derived Pharmaceutical Compositions - The present invention relates to the use of specific carbazole derivatives in the preparation of medicaments for the treatment, prevention and/or amelioration of disorders relating to pathological processes in lipid rafts. | 2010-03-11 |
20100063127 | Antioxidant Properties of Tryptophan from Human Milk - As tryptophan is not available in sufficient amounts in infant formula or other replacement milks, we describe herein the supplementation of these milks to attain a Trp concentration similar to that of human milk. Such supplemented milks provide greater protection against free radicals. | 2010-03-11 |
20100063128 | Indole compounds, a process for their preparation and pharmaceutical compositions containing them. - Compounds of formula (I): | 2010-03-11 |
20100063129 | METABOLITES OF WORTMANNIN ANALOGS AND METHODS OF USING THE SAME - Novel metabolites of wortmannin and wortmannin analogs and their use in inhibiting PI-3 kinase activity in mammals and the treatment and prevention of cancer or tumor formation in a subject are described herein. | 2010-03-11 |
20100063130 | METHOD FOR PROMOTING IMMUNE RESPONSE COMPRISING INHIBITING CD22 FUNCTION IN B CELLS - The purpose of the present invention is to elucidate a relationship between deregulation of signaling by CD22 and a rapid response of B cells by IgG-BCR and the like, and to provide a method capable of inducing a rapid immune response and defending against infection instead of vaccine. The present invention relates to a method for promoting an immune response causing such a strong proliferation of clones and production of a large amount of antibody-producing cells as those seen in the memory immune response even in the naive B cells expressing IgM-BCR and IgD-BCR by inhibiting the CD22 function in B cells; and to a method for screening a substance capable of promoting the immune response based on a change in the CD22 function in B cells. | 2010-03-11 |
20100063131 | PROMPT NUCLEIC ACID DELIVERY CARRIER COMPOSITION - An object of the present invention is to provide a carrier composition for nucleic acid delivery, which can efficiently deliver a nucleic acid into cells when a nucleic acid such as siRNA is administered to animal-derived cells or animals, and also has low toxicity and high safety, and a composition for nucleic acid delivery containing the carrier composition and nucleic acid. | 2010-03-11 |
20100063132 | SMALL INTERFERING RNA AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEPATITIS B COMPRISING THE SAME - The present invention relates to RNA interference mediated inhibition of Hepatitis B virus (HBV) by short interfering RNA (siRNA) molecules. Specially, siRNAs of the present invention which are double-stranded RNAs concern directing the sequence-specific degradation of viral RNA in mammalian cells. Disclosed is a DNA vector encoding the RNA molecules and synthesized siRNA molecules as well as method of therapeutic treatment for inhibition of HBV gene expression and viral replication by the administration of RNA molecules of the present invention. | 2010-03-11 |
20100063133 | ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ARENAVIRUS INFECTION - The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1. | 2010-03-11 |
20100063134 | TREATMENT OF NEURODEGENERATIVE DISEASE THROUGH INTRACRANIAL DELIVERY OF SIRNA - The present invention provides devices, small interfering RNA, and methods for treating a neurodegenerative disorder comprising the steps of surgically implanting a catheter so that a discharge portion of the catheter lies adjacent to a predetermined infusion site in a brain, and discharging through the discharge portion of the catheter a predetermined dosage of at least one substance capable of inhibiting production of at least one neurodegenerative protein. The present invention also provides valuable small interfering RNA vectors, and methods for treating neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Spinocerebellar Ataxia Type 1, Type 2, Type 3, and/or dentatorubral-pallidoluysian atrophy. | 2010-03-11 |
20100063135 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF - Polyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed. | 2010-03-11 |
20100063136 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES - N-Substituted sulfoximines are effective at controlling insects. | 2010-03-11 |
20100063137 | Cytotoxin Compound And Method of Isolation - The present invention concerns compounds derived from tunicates of the species | 2010-03-11 |
20100063138 | NOVEL SUBSTITUTED SULFAMIDE DERIVATIVES - The present invention is directed to novel substituted sulfamide derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives form in the treatment of anxiety and related disorders; bipolar depression and mania; depression; epilepsy and related disorders; epileptogenesis; glucose related disorders; lipid related disorders; migraine; obesity; pain; substance abuse and as neuroprotective agents. The present invention is further directed to a process for the preparation of the novel substituted sulfamide derivatives. | 2010-03-11 |
20100063139 | USE IN A COSMETIC COMPOSITION OF LIPOCHROMAN-6 TO ENHANCE THE RADIANCE OF THE COMPLEXION OF THE SKIN, ESPECIALLY THE SKIN OF THE FACE - The invention relates to the use, in a cosmetic composition intended for topical application to the skin, of lipochroman-6 as an active intended to enhance and/or restore the radiance of the complexion of the skin, especially the skin of the face. | 2010-03-11 |
20100063140 | WATER-SOLUBLE COMPOSITIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS - Water-soluble compositions comprising a lipophilic compound and a solubilizing agent of the general formula: | 2010-03-11 |
20100063141 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE - Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions that are affected by SGLT inhibition. | 2010-03-11 |
20100063142 | o/w/o EMULSION CONTAINING LIGNAN COMPOUNDS AND COMPOSITION CONTAINING THE SAME - An O/W/O emulsion composition having at least one of lignan-class compounds dissolved in an internal oil phase is disclosed. This composition can be produced by a process comprising the steps of 1) dissolving at least one of lignan-class compounds in oil or fat to prepare a lignan-class compound dissolving liquid; 2) emulsifying the lignan-class compound dissolving liquid in a water phase to form an O/W emulsion; and 3) further emulsifying the O/W emulsion in an oil phase to prepare an O/W/O emulsion. | 2010-03-11 |
20100063143 | PESTICIDE COMPOSITION COMPRISING PROPAMOCARB-HYDROCHLORIDE AND A N INSECTICIDE ACTIVE SUBSTANCE - The present invention relates to a pesticide composition intended for protecting plants, crops or seeds against phyto-pathogenic fungi or damaging insects, and the corresponding methods of treatment using the said composition. More precisely, the subject of the present invention is a pesticide composition based on propamocarb-HCl, an insecticide active substance and optionally a further fungicide active substance. | 2010-03-11 |
20100063144 | COMPOUNDS AND USES THEREOF - There is provided a compound of formula (I) wherein R | 2010-03-11 |
20100063145 | ACID CONTAINING OXALIPLATIN FORMULATIONS - There is provided a pharmaceutical liquid formulation of oxaliplatin for parenteral administration, said formulation having (i) oxaliplatin; (ii) water; and (iii) an acid wherein the acid is stabilising and is not malonic acid, lactic acid or oxalic acid. Methods of preparing the formulation are also disclosed. There is further provided the use of the formulation in the preparation of a medicament for the treatment of cancer and a method for treating cancer which comprises administering a therapeutic amount of a pharmaceutical formulation. | 2010-03-11 |
20100063146 | METHOD FOR TREATING DISORDERS RELATED TO COMPLEMENT ACTIVATION - A method for treating or preventing a complement activated T-cell mediated disorder in a subject includes administering a therapeutically effective amount of a pharmaceutical composition to the subject. The pharmaceutical composition includes at least one amidine compound or pharmaceutically acceptable salt. | 2010-03-11 |
20100063147 | Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases - The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine diseases, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof. | 2010-03-11 |
20100063148 | Pharmaceutical Combination - A composition of matter comprising in combination as component (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol compound, and as component (b) at least one antiepileptic, a pharmaceutical formulation and a dosage form comprising said composition of matter, and a method of treating pain, e.g. neuropathic pain, in which components (a) and (b) are administered simultaneously or sequentially to a mammal, whereby component (a) may be administered before or after component (b) and whereby components (a) or (b) are administered to the mammal either via the same or a different pathway of administration. | 2010-03-11 |
20100063149 | FOOD COMPOSITION FOR BINDING ACETALDEHYDE IN MOUTH AND IN DIGESTIVE TRACK, AND METHOD FOR THE PREPARATION OF THE COMPOSITION - The object of the invention comprises food compositions, to which one or more acetaldehyde-binding compounds are added. The purpose of the compositions is to reduce the amount of detrimental acetaldehyde in the area of the mouth, the pharynx, the oesophagus, the stomach, and the small and large intestines, and through this, to reduce the risk of developing cancers in these areas. | 2010-03-11 |
20100063150 | Aflatoxin Production Inhibitor and Method for Controlling Aflatoxin Contamination Using the Same - An object of the present invention is to provide an aflatoxin production inhibitor that inhibits aflatoxin production specifically and efficiently, is highly safe, and is practical, and an efficient production method thereof; and a method for controlling aflatoxin contamination that uses the aflatoxin production inhibitor. | 2010-03-11 |
20100063151 | ACYLAMIDE COMPOUNDS HAVING SECRETAGOGUE OR INDUCER ACTIVITY OF ADIPONECTIN - The present invention provides acylamide compounds, prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, and therapeutic methods by administering the same. | 2010-03-11 |
20100063152 | Method and Topical Formulation for Treating Localized Edema - Methods and formulations are provided for the treatment of localized edema, particularly localized edema resulting from chronic venous insufficiency. A metal ion sequestrant is topically administered to a subject afflicted with localized edema in combination with a permeation enhancer selected from methylsulfonylmethane and a combination of methylsulfonylmethane and dimethylsulfoxide. Topically administrable formulations for use in the aforementioned method are also provided. | 2010-03-11 |
20100063153 | ANTI-CHOLESTEROLEMIC COMPOUNDS AND METHODS OF USE - The present invention provides novel compounds with hypocholesteremic activity from crude | 2010-03-11 |
20100063154 | POLYMORPHS OF ACYL SULFONAMIDES - The application discloses novel polymorphic crystalline forms of 2-[4-Bromo-3-(3-chloro-5-cyano-phenoxy)-2-fluoro-phenyl]-N-(2-chloro-4-propionylsulfamoyl-phenyl)-acetamide, sodium salt (Ib) | 2010-03-11 |
20100063155 | N-(3-PHENYLPROPYL)BENZAMIDE DERIVATIVES - A compound of general formula (I): | 2010-03-11 |
20100063156 | ANANDAMIDE - The present invention describes provides the use of anandamide for the manufacture of a nutraceutical for oral intake preferably a medicament for reducing appetite, giving a satiety effect, preventing or reducing inflammatory bowel disease or preventing or reducing irritable bowel syndrome | 2010-03-11 |
20100063157 | CHEMICAL PROCESS AND NEW CRYSTALLINE FORM - The present invention relates to the preparation of a β | 2010-03-11 |
20100063158 | Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it - Crystalline form III of the compound of formula (I): | 2010-03-11 |
20100063159 | Use of dapsone as a neuroprotector in cerebral infarction - The use of dapsone is the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats and in patients suffering from acute cerebral infarction caused by thromboembolism. In both studies, dapsone displayed a reduction of between 70 and 90% in the adverse effects which occur as a consequence of the infarction. | 2010-03-11 |
20100063160 | POLYMORPHS OF O-DESMETHYL VENLAFAXINE SUCCINATE - The present invention relates to crystalline forms of O-desmethyl venlafaxine (ODV) succinate monohydrate, namely Forms I and II, in pure form and to novel processes for their preparation. The present invention provides a process for the preparation of Form II free of Form I and a process for the preparation of Form I free of Form II. The present invention provides direct methods for the preparation of ODV succinate Form II from ODV free base and for the preparation of ODV succinate Form I from ODV free base. | 2010-03-11 |
20100063161 | TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS - Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD-not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein. | 2010-03-11 |
20100063162 | METHOD FOR PREDICTING EFFICACY OF RAR-ALPHA AGONIST - A method for predicting preventive and/or therapeutic effect of an RAR-α agonist on a malignant tumor, which comprises the steps of measuring an expression level of a class of p160 family molecule and an expression level of a class of SP110 family molecule in a sample collected from the malignant tumor of a patient, and when the class of the p160 family molecule is dominant in a balance between the expression level of the class of the p160 family molecule and the expression level of the class of the SP110 family molecule, determining that an RAR-α agonist is effective for therapeutic treatment of the malignant tumor of the patient. | 2010-03-11 |
20100063163 | Extract Solution Comprising a B-Cryptoxanthin Component and Food and Drink Soaps - There are provided an extract solution to be added to food and drink containing a β-cryptoxanthin component consisting of an extract containing a β-cryptoxanthin component dissolved or dispersed in fat or oil or in a solution comprising an emulsifier and an extract solution to be added to soaps or cosmetics containing a β-cryptoxanthin component consisting of an extract containing a β-cryptoxanthin component dissolved or dispersed in fat or oil or in a solution comprising an emulsifier. There are also provided food and drink or soaps or cosmetics added with such extract solution containing a β-cryptoxanthin component. An extract containing a β-cryptoxanthin component derived from persimmon peel is preferable. | 2010-03-11 |
20100063164 | TRANSPARENT ZINC SULPHIDE HAVING A HIGH SPECIFIC SURFACE AREA - Zinc sulphide having a high specific surface area, a process for producing it and the use of this zinc sulphide. | 2010-03-11 |
20100063165 | Polyamide-Polyether Block Copolymer - Copolymers having linked internal polyether blocks and internal polyamide blocks have advantageous physical properties and solvent-gelling abilities. The copolymer may be prepared from a reaction mixture that contains 1,4-cyclohexane dicarboxylic acid (CHDA) and poly(alkyleneoxy) diamine (PAODA). Optionally, the reaction mixture contains no monofunctional compound reactive with either amine or carboxylic acid groups, however some of this monofunctional compound may be present. Dimer diamine and/or dimer acid may be present in the reaction mixture. A copolymer may also be prepared from a reaction mixture containing dimer acid and at least two diamine compound(s) including PAODA and short-chain aliphatic diamine having 2-6 carbons (SDA), wherein: a) the reaction mixture comprises x grams of PAODA and y grams of SDA, and x/(x+y) is 0.8-0.98; b) the reaction mixture weighs z grams, and x/z is at least 0.25; and c) the reaction mixture contains either no co-diacid, or comprises a small amount of co-diacid, wherein, if the reaction mixture comprises a small amount of co-diacid, then acid equivalents from co-diacid contribute less than 25% of the total acid equivalents present in the reaction mixture. | 2010-03-11 |
20100063166 | Thickners - Disclosed are thickeners comprising at least one polyfunctional alcohol ester of formula (I), where G is a moiety which is obtained by removing all alcoholic hydroxyl groups from a polyhydric alcohol; A is an alkylene group having 2 to 4 carbon atoms, where all identical or different alkylene groups may be randomly distributed or present in blocks, n is a number from 101 to 200, and the total of m+p represents the total number of alcoholic hydroxy groups in the polyhydric alcohol, and RCO is an acyl moiety of saturated or unsaturated, linear or branched fatty acids having 6 to 22 carbon atoms. | 2010-03-11 |
20100063167 | Agrochemical Formulations Comprising Co-Polymers Based on Ethylenically Unsaturated Dicarboxylic Mono and Diesters - The present invention comprises the use of formulations comprising at least one pesticide and at least one co-polymer comprising (a) at least one comonomer (a) selected from the group consisting of olefins, vinylethers, vinyl pyrrolidone and styrene; and (b) at least one comonomer (b) selected from the group consisting of ethylenically unsaturated dicarboxylic mono and diesters, wherein the alcohol moiety of the mono- or diester has the structure of formula I wherein R | 2010-03-11 |
20100063168 | IONOMERS WITH IONOGENIC GROUPS IN THE SIDECHAIN - The invention relates to ionomeric membranes, comprising a non- or partly-fluorinated, non-, partly- or fully-aromatic backbone and a non- or partly-fluorinated sidechain with ionogenic groups, or the non-ionic precursors thereof and a method for production of said ionomeric membranes. | 2010-03-11 |
20100063169 | PHOSPHORAMIDE ESTER FLAME RETARDANT AND RESINS CONTAINING SAME - Certain cyclic phosphoramide ester compounds useful, inter alia, as halogen-free flame-retardant compounds, are disclosed. The compounds are particularly useful for providing flame retarded polyurethane foams. (I) | 2010-03-11 |
20100063170 | CARBON-CONTAINING MODIFIED POLYSTYRENE TYPE RESIN PARTICLE, FOAMABLE CARBON-CONTAINING MODIFIED POLYSTYRENE TYPE RESIN PARTICLE, CARBON-CONTAINING MODIFIED POLYSTYRENE TYPE RESIN FOAMED PARTICLE, CARBON-CONTAINING MODIFIED POLYSTYRENE TYPE RESIN FOAMED MOLDED PRODUCT, AND PRODUCTION METHODS THEREOF - A carbon-containing modified polystyrene type resin particle of the present invention includes: a carbon-containing polypropylene type resin, and a polystyrene type resin in an amount of not less than 100 parts by weight but less than 400 parts by weight per 100 parts by weight of the carbon-containing polypropylene type resin, wherein the polystyrene type resin ratio at the central part of the particle is at least 1.2 times the polystyrene type resin ratio of the overall particle, the polystyrene type resin ratio being calculated by using the ratio (D698/D1376) of absorbances at 698 cm | 2010-03-11 |
20100063171 | METHOD FOR PRODUCING EMULSION POLYMERS - The present invention relates to a process for preparing emulsion polymer particles having a core/shell structure and also to their use in paints, paper coatings, foams, and cosmetics. | 2010-03-11 |
20100063172 | SYSTEM AND METHOD FOR MANUFACTURING MOLDED STRUCTURES USING A HIGH DENSITY MATRIX OF MICROPARTICLES - A method for manufacturing a molded structure includes the provisioning of a first mixture which includes microparticles and a liquid-phase mixture of resin and curing agent. The first mixture is centrifuged to extract a volume of the liquid-phase resin and curing agent mixture from the first mixture, the centrifuging process resulting in the formation of a liquid-phase matrix of microparticles which are at least partially-coated with liquid-phase resin and curing agent. The liquid-phase matrix of at least partially coated microparticles is cured to form a solid-phase matrix of microparticles, thereby providing the molded structure. | 2010-03-11 |
20100063173 | HOT MELT ADHESIVE COMPOSITION - An adhesive composition is described that is particularly useful for application to the plastic nonwoven materials found in personal hygienic articles. The composition includes first and second ethylene vinyl acetate copolymers. The first copolymer has a high molecular weight characterized by a melt viscosity at 150° C., of 100 Pascals per second or more. The second copolymer has a low molecular weight characterized by a melt viscosity at 150° C. of 50 Pascals per second or less. The second copolymer is present in an amount by weight percent less than or equal to the amount by weight percent of the first ethylene vinyl acetate copolymer. The composition also includes at least one tackifier resin, a hydrocarbon wax present in an amount from 0.5% to 10% by weight of the composition; and, a liquid plasticizer present in an amount up to 20% by weight of the composition. | 2010-03-11 |
20100063174 | SYSTEMS AND METHODS FOR CONTROLLING AND FORMING POLYMER GELS - In preferred embodiments, the present invention provides methods of controllably making a vinyl polymer hydrogel having desired physical properties without chemical cross links or radiation. The gelation process is modulated by controlling, for example, the temperature of a resultant vinyl polymer mixture having a gellant or using active ingredients provided in an inactive gellant complex. In accordance with a preferred embodiment, the method of manufacturing a vinyl polymer hydrogel includes the steps of providing a vinyl polymer solution comprising a vinyl polymer dissolved in a first solvent; heating the vinyl polymer solution to a temperature elevated above the melting point of the physical associations of the vinyl polymer, mixing the vinyl polymer solution with a gellant, wherein the resulting mixture has a higher Flory interaction parameter than the vinyl polymer solution; inducing gelation of the mixture of vinyl polymer solution and gellant; and controlling the gelation rate to form a viscoelastic solution, wherein workability is maintained for a predetermined period, thereby making a vinyl polymer hydrogel having the desired physical property. In further preferred embodiments, the present invention provides physically crosslinked hydrogels produced by controlled gelation of viscoelastic solution wherein workability is maintained for a predetermined period. In another aspect, the present invention provides kits for use in repairing intervertebral disks or articulated joints including a dispenser and single use containers housing components that form the vinyl polymer hydrogel. | 2010-03-11 |
20100063175 | Composition - A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal. | 2010-03-11 |
20100063176 | PASTE-TYPE DENTAL CEMENT - To provide a paste-type dental cement capable of being used properly for temporary adhering or temporary filling, a paste-type dental cement, which comprises a phosphoric acid and/or a polymer of α-β unsaturated carboxylic acid, an oxide powder capable of reacting with the phosphoric acid and/or the polymer of α-β unsaturated carboxylic acid, and a water, further includes a liquid not reacting with the oxide powder. | 2010-03-11 |
20100063177 | BIODEGRADABLE RESIN COMPOSITION - The invention relates to a biodegradable resin composition containing a biodegradable resin, a plasticizer and a crystal nucleus agent, the plasticizer being a compound containing two or more ester groups in the molecule thereof, wherein at least one alcohol component constituting the ester contains an alkylene oxide having 2 to 3 carbon atoms, added in the average amount of 0.5 to 5 moles per one hydroxyl group, and the crystal nucleus agent is a mixture of the following crystal nucleus agent (1) and crystal nucleus agent (2); the crystal nucleus agent (1) being the following crystal nucleus agent (1-1) or crystal nucleus agent (1-2): crystal nucleus agent (1-1): at least one selected from compounds having a hydroxyl group and an amide group in the molecule thereof; and crystal nucleus agent (1-2): at least one selected from hydroxy fatty acid esters; crystal nucleus agent (2): at least one selected from a metal salt of phenylphosphonic acid, a metal salt of a phosphate, a metal salt of an aromatic dialkyl sulfonate, a metal salt of rosinic acids, an aromatic carboxylic acid amide, rosinic acid amide, carbohydrazides, N-substituted ureas, salts of melamine compounds and uracils. | 2010-03-11 |
20100063178 | Esters Of Cyclohexane Polycarboxylic Acids As Plasticizers In Rubber Compounds - It has been discovered that the use of a plasticizer, an ester of a cyclohexanepolycarboxylic acid, especially a 1,2-cyclohexanedicarboxylic acid ester, that is environmentally non-toxic, can replace environmentally unfriendly phthalate plasticizers, such as dioctyl phthalates used in vulcanizable rubber compositions, especially for tires, on a one to one weight basis (phr) without sacrificing beneficial rubber properties. | 2010-03-11 |
20100063179 | SOLVENT EXTRACTION MICROENCAPSULATION WITH TUNABLE EXTRACTION RATES - The present disclosure relates to processes for preparing microparticles using a solvent extraction technique, including controlled addition and/or removal of the extraction phase. | 2010-03-11 |
20100063180 | FIRE PROTECTION AND/OR FIRE FIGHTING ADDITIVES, ASSOCIATED COMPOSITIONS, AND ASSOCIATED METHODS - Fire protection and/or fire fighting additives including a water-swellable polymer, a water immiscible phase, an emulsifier, an inverter, and a remainder water are disclosed. The water-swellable polymer is acrylamide-free and crosslinked and may be prepared by inverse phase polymerization. Such fire protection and/or fire fighting additives and fire protection and/or fire fighting compositions made using the additives exhibit exceptionally low corrosion properties. For example, when contacted with any one of a 2024-T3 aluminum alloy, 4130 steel, yellow brass, or AZ31B magnesium alloy, the corrosion rate is less than about 5 mils/yr for the fire protection and/or fire fighting additives. | 2010-03-11 |
20100063181 | COATING SYSTEM - A curable composition comprising
| 2010-03-11 |
20100063182 | EPOXY COMPOSITION - There is disclosed an epoxy composition containing at least two kinds of epoxy compounds selected from the epoxy compounds of the formula (1): | 2010-03-11 |
20100063183 | INTERCALATION AGENT FREE COMPOSITIONS USEFUL TO MAKE NANOCOMPOSITE POLYMERS - A two step method for preparing a filler composition, the filler composition useful to prepare a nanocomposite polymer. The first step is to disperse a water dispersible filler material in a liquid comprising water to form a dispersion. The second step is to replace at least a portion of the water of the liquid with an organic solvent to form the filler composition, the water concentration of the liquid of the filler composition being less than six percent by weight, the average size of at least one dimension of the filler material being less than two hundred nanometers upon examination by transmission electron microscopy of a representative freeze dried sample of the dispersion of the first step. A nanocomposite polymer can be prepared by mixing the above-made filler composition with one or more polymer, polymer component, monomer or prepolymer to produce a polymer containing a filler having an average size of at least one dimension of the filler of less than two hundred nanometers upon examination by transmission electron microscopy of a representative sample of the polymer. In addition, an epoxy resin composition useful for making a cured epoxy nanocomposite polymer, the epoxy resin composition made by a two step process. The first step is to mix an epoxy resin with the filler composition to form an epoxy resin mixture. The second step is to remove organic solvent from the epoxy resin mixture to form the epoxy resin composition. And, a nanocomposite polymer, made by the step of mixing the filler composition with one or more polymer, polymer component, monomer or prepolymer to produce a polymer containing a filler having an average size of at least one dimension of the filler of less than two hundred nanometers upon examination by transmission electron microscopy of a representative sample of the polymer. | 2010-03-11 |
20100063184 | LOW TEMPERATURE CURING ACRYLATE AND MALEIMIDE BASED FORMULATIONS AND METHODS FOR USE THEREOF - The present invention is based on the discovery that certain electron poor olefins combined with nucleophiles and a base catalyst are useful as adhesive compositions for the electronic packaging industry. In particular, the adhesive formulations set forth herein are useful as low temperature curing formulations with high adhesion to a variety of substrates. Invention formulations typically cure at about 80° C. and have a potlife of about 24 hours. The formulations cure by the well-known Michael addition reaction. | 2010-03-11 |
20100063185 | Curable Silicone Composition and Electronic Component - A curable silicone composition comprising at least the following components: (A) an epoxy-containing organopolysiloxane; (B) a curing agent for epoxy resin; and (C) an epoxy compound represented by the specific general formula; is characterized by excellent handleability and reduced oil-bleeding, and, when cured, forms a cured body of excellent flexibility and adhesion. | 2010-03-11 |
20100063186 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME - The disclosure is generally related to a washable ink composition and a writing instrument containing the same. The disclosure provides a washable ink composition that includes a pigment capsule having a polymer matrix formed of a resin selected from the group consisting of aminoplast resins, epoxy resins, and combinations thereof, and at least one colorant contained in the polymer matrix; and at least one washing aid having at least 4 ethylene oxide units per molecule of washing aid and/or at least one washing aid having an HLB value of at least 12. | 2010-03-11 |
20100063187 | COMPOSITIONS CONTAINING PHOSPHONATE-FUNCTIONAL PARTICLES - Phosphonatoalkylsilyl-functional particles have high stability and resistance to agglomeration. When used in curable binder compositions, the particles contribute to a high level of scratch resistance. | 2010-03-11 |
20100063188 | METHOD FOR COATING SURFACES AND AQUEOUS FORMULATIONS SUITED THEREFOR - A method for coating surfaces by treatment with a substantially paraffin-free aqueous formulation, comprising
| 2010-03-11 |
20100063189 | RUBBER COMPOSITION FOR TYRES INCORPORATING A NOVEL ANTIOXIDANT SYSTEM - Rubber composition, especially for a tyre, based on at least one diene elastomer, a reinforcing filler, a crosslinking system and an antioxidant system, wherein said antioxidant system comprises at least two antioxidants “A” and “B”:
| 2010-03-11 |
20100063190 | SILICONE COMPOSITION - The present invention relates to silicone compositions which comprise at least one ketoximosilane-terminated polydiorganosiloxane and also at least one alkoxysilane. These compositions are neutrally crosslinking and combine a low odour with high adhesion and good storage stability. | 2010-03-11 |
20100063191 | POLYAMIDE RESIN COMPOSITION PELLET BLEND, MOLD ARTICLE AND METHOD FOR MANUFACTURING PELLET BLEND - Provided is a pellet blend excellent in both of the surface design and the high cycle performance. A pellet blend containing: a polyamide resin composition pellet (A) containing 30 to 100% by weight of a polyamide resin (a) and 70 to 0% by weight of an inorganic filler (b), the polyamide resin (a) containing at least a crystalline polyamide resin showing a crystallization-temperature on cooling stage (Tc) of 210° C. or lower measured by differential scanning calorimeter and/or an amorphous polyamide resin (a-1); and a lubricant pellet (B) containing 1 to 30% by weight (on the basis of the lubricant pellet) of a lubricant (c) in a polyamide resin (a-3), at a ratio by weight of polyamide resin composition pellet (A)/lubricant pellet (B) of (80 to 99.5)/(20 to 0.5). | 2010-03-11 |
20100063192 | POLYARYLENE SULFIDE RESIN COMPOSITION AND A MOLDED ARTICLE FORMED THEREFROM - A resin composition including the following components (A) to (C):
| 2010-03-11 |
20100063193 | Process for manufacturing outdoor artificial stone boards with methacrylate resin by means of the vibro-compression under vacuum system - The invention relates to a process for manufacturing artificial stone boards especially suitable for outdoors comprising the phases of:
| 2010-03-11 |
20100063194 | Coating composition for electrical conductors and method of producing such a composition - The invention relates to a composition for coating electrical conductors and a method of producing such a composition. | 2010-03-11 |
20100063195 | USE OF NANOPARTICULATE ORGANIC PIGMENTS IN PAINTS AND COATINGS - A protective and decorative coating composition including about 2 to 10 different colorants which in combination with a resinous composition produce a desired visible coating. A majority of the colorants has a maximum haze of about 10% and exhibits an absorbance peak in the visible spectrum wherein at least about 50% of the total absorbance in the visible spectrum occurs at wavelengths within about 50 nm of the wavelength of the peak absorbance. | 2010-03-11 |
20100063196 | UNIVERSAL PRIMER COMPOSITIONS AND METHODS - A composition for and method for bonding a substrate. In general, applied to a substrate will be a primer composition that includes an adhesion promoter, which is an adduct prepared by the reaction of at least one aromatic polyisocyanate compound, with an active hydrogen containing moiety of an organofunctional silane, and a prepolymer derived from the reaction of at least one aliphatic polyisocyanate and a polyol, and is at least partially reacted with an active hydrogen containing moiety of an organofunctional silane. | 2010-03-11 |
20100063197 | COMPOSITIONS AND METHODS FOR IMPARTING WATER AND OIL REPELLENCY TO FIBERS AND ARTICLES THEREOF - Described herein are compositions and methods for imparting water and oil repellency to fibers. The compositions are composed of (a) a fluorinated polyurethane having a plurality of ionizable groups and (b) an acrylic polymer. Also described herein are fibers and articles treated with the compositions and methods described herein. | 2010-03-11 |
20100063198 | ADHESIVE AND MULTILAYER STRUCTURE HAVING THE SAME - It is an object of the invention to provide polypropylene adhesives which have excellent adhesion to polar materials and exhibit particularly excellent adhesion after high-speed cast film processing, stretching or extrusion coating, and are excellent in blushing resistance, and multilayer structures having the adhesives. | 2010-03-11 |
20100063199 | GRAFT COPOLYMER FOR TRANSPARENT THERMOPLASTIC POLYURETHANE RESIN, PREPARATION METHOD THEREOF, AND POLYURETHANE RESIN COMPOSITION CONTAINING THE SAME - The present invention relates to a graft copolymer for transparent thermoplastic polyurethane resin, a preparing method thereof and a polyurethane resin composition comprising the same, more precisely a graft copolymer for transparent thermoplastic polyurethane resin prepared by graft copolymerization of (a) 50-85 weight % of rubber latex having multi-layered structure composed of an inner layer and an outer layer comprising a conjugated diene monomer and an ethylenically unsaturated aromatic compound in which the refraction index of the inner layer is greater than that of the outer layer; and (b) 15-50 weight % of a C | 2010-03-11 |
20100063200 | AQUEOUS ROMP-BASED MONOLITH MATERIALS AND METHODS FOR MAKING - A water soluble ROMP catalyst, which has high catalytic efficiency for ring opening metathesis is use in the preparation of polymeric blends for use in monolithic columns. In one embodiments a method for making a polymeric blend is discolosed comprising reaction of a water-soluble ROMP catalyst with a norbornene-substituted cycloolefin polymer or a polynorbornene polymer precursor, and wherein the contacting occurs in an aqueous or polar solvent in the presence of a solid support. In another embodiment a monolithic bed is disclosed comprising the water-soluble ROMP catalyst immobilized on a surface of a solid support. Also disclosed is a monolithic bed comprising: a polymer blend, the polymer blend produced from contacting a water soluble ROMP catalyst with a norbornene-substituted cycloolefin polymer or a polynorbornene polymer precursor; and wherein the contacting occurs in an aqueous or polar solvent in the presence of a solid support. | 2010-03-11 |
20100063201 | METHOD FOR MANUFACTURING PIGMENT DISPERSION, AND AQUEOUS INK FOR INKJET RECORDING AND METHOD FOR MANUFACTURING THE SAME - A method for manufacturing a pigment dispersion is provided. The method includes mixing a water-insoluble resin, carbon black, a neutralizing agent, an organic solvent, an anionic low-molecular weight surfactant and an aqueous medium to form an aqueous dispersion; and removing at least a part of the organic solvent from the aqueous dispersion. Further, a method for manufacturing an aqueous ink for inkjet recording and an aqueous ink for inkjet recording are provided. | 2010-03-11 |
20100063202 | Methods of Making Siloxy-Amine Functionalized Rubbery Polymers and Uses Thereof in Rubber Compositions for Tires - The invention includes a siloxy-amine functionalized rubbery polymer, which exhibits good reinforcing characteristics and filler dispersing effect, a method for making, and a rubber composition including the same. In one embodiment, a process for manufacturing includes polymerizing a conjugated diene monomer using an organolithium compound as an initiator in a hydrocarbon solvent. Next, an active terminal end of the polymer is reacted with a functionalized terminating agent represented by: | 2010-03-11 |
20100063203 | COATING COMPOSITION - A coating composition containing a build-up organic pigment fine-particle. | 2010-03-11 |
20100063204 | HYPER-BRANCHED POLYMER OF AN ESTER TYPE, AS WELL AS A TONER FOR ELECTROPHOTOGRAPHY AND A PIGMENT MASTER BATCH USING THE SAME - [Problems] To produce a hyper-branched polymer having excellent resin strength, a good anti-blocking property and less environmental dependence. | 2010-03-11 |
20100063205 | METHOD FOR DISSOLVING ARAMID POLYMER IN SULFURIC ACID USING A DOUBLE SHAFT KNEADER - A method for dissolving an aramid polymer in sulfuric acid using a double shaft kneader, comprising the steps: dosing the polymer and the solvent into the kneader, mixing the polymer and the solvent to dissolve the polymer in the solvent for obtaining a solution, degassing the solution to obtain a spin dope, and transporting the spin dope out of the kneader, wherein the polymer is an aramid polymer and the solvent is sulfuric acid, and whereby the aramid polymer is dosed into the kneader prior to dosing the sulfuric acid into the kneader. | 2010-03-11 |
20100063206 | Method and Apparatus for the Fluorination of Plastics - The gas-phase fluorination of plastic articles is effected in a reaction chamber | 2010-03-11 |
20100063207 | POLYOLEFIN COMPOSITIONS HAVING LOW HARDNESS AND LOW GLOSS - A polyolefin composition comprising, in percent by weight: A) 10-25% of a propylene homopolymer or copolymer with up to 8% of comonomer(s); B) 75-90% of a copolymer of ethylene and (i) propylene or (ii) CH | 2010-03-11 |
20100063208 | Multicomponent Taggant Fibers and Method - Taggant fibers and methods of use provide for enhanced protection and security when the fibers are used in documents such as land titles, currency, passports and other documents of value. The taggant fibers consist of a minimum of two separate zones with each zone containing a different taggant to emit different wave lengths when excited. The taggants may consist of organic or inorganic compounds as are conventionally known and can be manufactured using for example polymeric materials which can be extruded during the fiber manufacturing process. Authentication of the fibers or documents containing such fibers can be readily viewed using conventional techniques. | 2010-03-11 |
20100063209 | DEGRADABLE THIOL-ENE POLYMERS - A thiol-ene polymeric material is disclosed. The material is produced by the photopolymerization of reactants having thiol and olefin moieties. The material can incorporate encapsulated components, including cells. Additionally, the material can be derivatized by reacting the polymeric material with components such as proteins. | 2010-03-11 |
20100063210 | METHACRYLIC RESIN COMPOSITION, RESIN MODIFIER, AND MOLDED ARTICLE - A methacrylic resin composition in which a star block copolymer (B) in the form of particles is dispersed in a matrix (A) composed of a methacrylic resin comprising not less than 50% by mass of a methyl methacrylate unit. The methacrylic resin composition is obtained by bulk-polymerizing or solution-polymerizing 100 parts by mass of a monomer mixture (A′) containing 50 to 100% by mass of methyl methacrylate and 0 to 50% by mass of other vinyl monomer copolymerizable with the methyl methacrylate, in the presence of 1 to 80 parts by mass of the star block copolymer (B) comprising a polymer block (a) composed of a (meth)acrylic acid alkyl ester unit and a polymer block (b) composed of a conjugated diene compound unit, until the polymerization conversion of the monomer reaches 70% by mass or more. | 2010-03-11 |
20100063211 | ARBORESCENT POLYMERS AND PROCESS FOR MAKING SAME - The present invention relates to arborescent polymers and to a process for making same. In one embodiment, the present invention relates to arborescent polymers formed from at least one inimer and at least one isoolefin that have been end-functionalized with a polymer or copolymer having a low glass transition temperature (T | 2010-03-11 |